Zymetx, Inc.

Oklahoma City, OK 73104

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $918K
First Award Date 05/15/00
Most Recent Award Date 03/01/03

Key Personnel

Last Name Name Awards Contact
Ojwang Joshua O Ojwang 4

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/03 - 02/29/04

DESCRIPTION (provided by applicant): Lower respiratory tract infections such as bronchiolitis and pneumonia in pediatrics and some adults are caused by respiratory syncytial virus. The therapies include the controversial ribavirin for treatment or humanized RSV monoclonal antibodies (Synagis) for prevention. The cos...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/02 - 06/30/03

DESCRIPTION (Provided by applicant): Hepatitis C viral infection is the most common chronic bloodborne infection in the United States. There are about 36,000 new infections every year, and 25-30 percent of those infections are symptomatic. It is estimated that 3.9 million (1.8 percent) Americans have been infected. Chronic liver disease, which i...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/05/02 - 02/28/03

DESCRIPTION (provided by applicant): Lower respiratory tract infections such as bronchiolitis and pneumonia in pediatrics and some adults are caused by respiratory syncytial virus. The therapies include the controversial ribavirin for treatment or humanized RSV monoclonal antibodies (Synagis) for prevention. The cos...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/15/00 - 06/13/01

Respiratory syncytial virus (RSV) causes lower respiratory tract infections such as bronchiolitis and pneumonia in infants, young children and adults. In the absence of an effective vaccine and less controversial compounds to prevent or ameliorate RSV infections, RSV remains a serious health threat and a sustained effort must be mounted to find ...